Showing 1821-1830 of 2736 results for "".
- Plastic Surgeon Dr. Howard Levinson Named New PSF Presidenthttps://modernaesthetics.com/news/plastic-surgeon-dr-howard-levinson-named-new-psf-president/2473330/Howard Levinson, MD, FACS, is the new president of The Plastic Surgery Foundation (PSF), the research and international activity arm of the American Society of Plastic Surgeons (ASPS). Dr. Levinson took office Oct. 30 in Boston during Plastic Surgery The Meeting, the Soci
- Dr. Gregory Greco Named New ASPS Presidenthttps://modernaesthetics.com/news/dr-gregory-greco-named-new-asps-president/2473329/Gregory Greco, DO, FACS, is the new president of The American Society of Plastic Surgeons. He took office October 30, in Boston during Plastic Surgery: The Meeting, the society’s annual scientific meeting. Dr. Greco will serve as president of the society for one year. “
- Maryland Facial Plastic Surgeon Dr. Theda Kontis Named New AAFPRS Presidenthttps://modernaesthetics.com/news/maryland-facial-plastic-surgeon-dr-theda-kontis-named-new-aafprs-president/2473326/Dr. Theda Kontis, MD, is the new President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). She formally took office as AAFPRS President during the AAFPRS Annual Business Meeting on October 21, 2022. She will serve as president during the 2022-2023 ter
- Evio Beauty Supports Domestic Violence Survivorshttps://modernaesthetics.com/news/evio-beauty-supports-domestic-violence-survivors/2473319/Evio Beauty is teaming up with FreeFrom, a US-based non-profit organization dedicated to helping survivors of intimate partner violence achieve economic justice and long-term financial stability. Evio will donate one dollar from every sale of their Lip Serum (in any shade) to FreeFrom.
- U.S. FDA Clears EndyMed’s Pure Laser Hair Removal Devicehttps://modernaesthetics.com/news/us-fda-clears-endymeds-pure-laser-hair-removal-device/2473318/The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales. The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. The Company intends to commence marketing in the US th
- Right to Repair: How Developments Could Affect Aesthetics Practiceshttps://modernaesthetics.com/news/right-to-repair-how-developments-could-affect-aesthetics-practices/2473311/Recent action on the federal level has renewed interest in “Right to Repair” legislation, and the medical aesthetics industry is eyeing developments that might directly impact aesthetic practices and medspas. Right to Repair legislation dates back to the 1970s, and mos
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &